Until recently, cell replacement therapy as a treatment for patients with diabetes required a large, unsustainable supply of donors. The 2000’s have marked the beginning of the golden era of diabetes research. Currently, the main goal in diabetes research is to isolate and investigate the genetic intricacies of the process called “transdifferentiation”. If we can perfect transdifferentiation, we can essentially turn any cell in the body into a pancreatic B cell. Other factors play a role in this science. The immunosuppressive drugs the recipient uses could lead to further complications since said patient will be slightly immunocompromised. However, the key of this fantastic new research is that we are the verge of curing diabetes. If scientists can figure out how to initiate transdifferrentiation successfully, we could ultimately grow new pancreatic B cells from any stem cell in the body.